IQVIA Holdings Inc. (IQV)

146.48
0.78 0.54
NYSE : Health Services
Prev Close 145.70
Open 145.53
Day Low/High 144.64 / 146.59
52 Wk Low/High 104.90 / 164.13
Volume 907.30K
Avg Volume 1.35M
Exchange NYSE
Shares Outstanding 194.04M
Market Cap 27.74B
EPS 1.30
P/E Ratio 26.06
Div & Yield N.A. (N.A)

Latest News

IQVIA Launches Orchestrated Patient Engagement

IQVIA Launches Orchestrated Patient Engagement

IQVIA™ (NYSE: IQV) today announced the launch of Orchestrated Patient Engagement (OPE), a new cloud-based software as a service (SaaS) solution that helps close the gap between life sciences companies and patients.

IQVIA Launches IQVIA Consumer Health To Meet The Growing Business Needs Of The Retail Health Sector

IQVIA Launches IQVIA Consumer Health To Meet The Growing Business Needs Of The Retail Health Sector

IQVIA™ (NYSE:IQV) today announced the launch of IQVIA Consumer Health, dedicated to supporting companies to drive innovation, operate more efficiently, optimize expanding product portfolios, and revitalize existing brands.

IQVIA Holdings Achieves #34 Analyst Rank, Surpassing Danaher

IQVIA Holdings Achieves #34 Analyst Rank, Surpassing Danaher

In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, IQVIA Holdings Inc has taken over the #34 spot from Danaher Corp , according to ETF Channel. Below is a chart of IQVIA Holdings Inc versus Danaher Corp plotting their respective rank within the S&P 500 over time (IQV plotted in blue; DHR plotted in green): In forming the rank, the analyst opinions from the major brokerage houses were tallied, and averaged; then, the underlying components were ranked according to those averages.

IQVIA Collaborates With Cancer Researchers To Advance Use Of Real World Evidence

IQVIA Collaborates With Cancer Researchers To Advance Use Of Real World Evidence

IQVIA™ (NYSE:IQV) is proud to announce its collaboration with Friends of Cancer Research in a cross-industry effort to advance acceptance and drive future uses of real world evidence (RWE).

IQVIA MedTech Launches Enhanced EQMS Including EU MDR Support

IQVIA MedTech Launches Enhanced EQMS Including EU MDR Support

IQVIA™ (NYSE:IQV) today announced the launch of its latest release of the IQVIA SmartSolve® Enterprise Quality Management Solution (EQMS).

IQVIA Recommends Shareholders Reject "Mini-Tender" Offer By TRC Capital Investment Corporation

IQVIA Recommends Shareholders Reject "Mini-Tender" Offer By TRC Capital Investment Corporation

IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV) today announced that it received notice of an unsolicited "mini-tender" offer by TRC Capital Investment Corporation (TRC Capital) to purchase up to one million IQVIA common shares at a price of $148.

IQVIA To Participate In Baird 2019 Global Healthcare Conference On September 4, 2019

IQVIA To Participate In Baird 2019 Global Healthcare Conference On September 4, 2019

IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV) announced today that Ari Bousbib, chairman and chief executive officer, will speak at the Baird 2019 Global Healthcare Conference in New York, NY on Wednesday, September 4, 2019 at 9:40 a.

IQVIA Launches Patient Portal To Transform The Clinical Trial Experience

IQVIA Launches Patient Portal To Transform The Clinical Trial Experience

IQVIA™ (NYSE:IQV) announces its launch of the IQVIA Patient Portal, a global web-based solution built on a leading health cloud platform.

IQVIA Announces Repurchase Of Common Stock

IQVIA Announces Repurchase Of Common Stock

IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV) today announced that it has agreed to purchase an aggregate of 1,000,000 shares (the "Shares") of its common stock in a private transaction from certain of its existing stockholders (the "Repurchase").

IQVIA Named Real World Evidence Market Leader

IQVIA Named Real World Evidence Market Leader

IQVIA™ (NYSE:IQV) today announced that a new Life Science Strategy Group (LSSG) report named IQVIA the market leader in real world data and real world evidence services.

IQVIA's Cynthia Verst Honored On 2019 PharmaVOICE 100 List

IQVIA's Cynthia Verst Honored On 2019 PharmaVOICE 100 List

IQVIA™ (NYSE:IQV) today announced that Cynthia Verst, IQVIA's president, Design and Delivery Innovation, Research & Development Solutions, has been named to PharmaVOICE magazine's annual list of the 100 most influential and inspiring individuals within...

IQVIA Announces Pricing Of Offering Of Senior Notes

IQVIA Announces Pricing Of Offering Of Senior Notes

IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV) today announced that its wholly owned subsidiary, IQVIA Inc.

IQVIA Announces Offering Of Senior Notes

IQVIA Announces Offering Of Senior Notes

IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV) today announced that its wholly owned subsidiary, IQVIA Inc.

IQVIA Reports Second-Quarter 2019 Results, Raises Full-Year Revenue And Adjusted Diluted EPS Guidance

IQVIA Reports Second-Quarter 2019 Results, Raises Full-Year Revenue And Adjusted Diluted EPS Guidance

IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and contract research services to the life sciences industry, today reported financial results for the quarter ended June 30, 2019.

IQVIA Holdings Expected to Earn $1.49 a Share

IQVIA Holdings Expected to Earn $1.49 a Share

IQVIA Holdings revenue expected to rise 4.8% to $2.7 billion.

IQVIA Awarded Frost & Sullivan's Life Sciences Product Leadership Award For Its Advanced Quality Management Technology Solution

IQVIA Awarded Frost & Sullivan's Life Sciences Product Leadership Award For Its Advanced Quality Management Technology Solution

IQVIA™ (NYSE:IQV) today announced it has received the Frost & Sullivan's 2018 Global Enterprise Quality Management Solutions for Life Sciences Product Leadership award.

IQVIA Named To Forbes 2019 List Of America's Best Employers For Women

IQVIA Named To Forbes 2019 List Of America's Best Employers For Women

IQVIA Holdings Inc. ("IQVIA™") (NYSE: IQV) has been named to the Forbes 2019 list of America's Best Employers for Women.

IQVIA To Announce Second-Quarter 2019 Results On July 24, 2019

IQVIA To Announce Second-Quarter 2019 Results On July 24, 2019

IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV), will announce its second-quarter 2019 financial results before the market opens on Wednesday, July 24, 2019.

IQVIA Introduces Patient Centered Endpoints Solution With Transformative ECOA Technology Platform

IQVIA Introduces Patient Centered Endpoints Solution With Transformative ECOA Technology Platform

IQVIA™ (NYSE:IQV) today announced the launch of the Patient Centered Endpoints (PCE) solution, an innovative science and technology-enabled approach that captures quantified evidence of patients' experiences during clinical trials and real world studies.

Chiesi Group Selects IQVIA's OCE Technology Platform To Develop A Customer Centric Ecosystem Across The Organization

Chiesi Group Selects IQVIA's OCE Technology Platform To Develop A Customer Centric Ecosystem Across The Organization

IQVIA ™ (NYSE:IQV) today announced that Chiesi Farmaceutici, the international research-focused healthcare Group (Chiesi Group) is leveraging IQVIA Technologies' Orchestrated Customer Engagement (OCE) technology platform to enhance customer proximity and...

IQVIA's OCE Technology Platform Selected By Ferring Pharmaceuticals

IQVIA's OCE Technology Platform Selected By Ferring Pharmaceuticals

IQVIA™ (NYSE:IQV) today announced that Ferring Pharmaceuticals, a global leader in reproductive health, women's health and other medical therapies, has selected IQVIA Technologies' Orchestrated Customer Engagement (OCE) platform for global deployment...

IQVIA's OCE Technology Platform Selected By Zambon To Establish A Global Multichannel Commercial Engagement Model For OTC Business

IQVIA's OCE Technology Platform Selected By Zambon To Establish A Global Multichannel Commercial Engagement Model For OTC Business

IQVIA™ (NYSE:IQV) today announced that Zambon, an Italian multinational pharmaceutical and fine-chemical company, has selected Orchestrated Customer Engagement (OCE), IQVIA Technologies' transformative commercial engagement technology, to maximize...

IQVIA Real World Capabilities And Expertise Support Path To Label Expansion

IQVIA Real World Capabilities And Expertise Support Path To Label Expansion

IQVIA™ (NYSE:IQV) is pleased to have provided support towards the approval from the U.

IQVIA™ Institute For Human Data Science Releases Global Oncology Trends 2019 Study: Record Number Of Cancer Drugs Launched In 2018 Across 17 Indications

IQVIA™ Institute For Human Data Science Releases Global Oncology Trends 2019 Study: Record Number Of Cancer Drugs Launched In 2018 Across 17 Indications

The IQVIA™ Institute for Human Data Science found in its latest report, Global Oncology Trends 2019: Therapeutics, Clinical Development and Health System Implications, that in 2018 a record-setting 15 new active substance (NAS) oncology treatments with 17...

IQVIA Women Leaders Recognized For Their Outstanding Contributions To The Advancement Of Healthcare

IQVIA Women Leaders Recognized For Their Outstanding Contributions To The Advancement Of Healthcare

IQVIA™ (NYSE:IQV) today announced that three of the company's women leaders have received significant awards for their leadership, vision and strategic abilities to drive disruptive technologies, improve health outcomes, and advance innovation.

IQVIA To Participate In William Blair Growth Stock Conference On June 5, 2019

IQVIA To Participate In William Blair Growth Stock Conference On June 5, 2019

IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV), announced today that Ari Bousbib, chairman and chief executive officer, will speak at the William Blair 39th Annual Growth Stock Conference in Chicago, IL on Wednesday, June 5, 2019 at 10:40 a.

IQVIA To Host Financial Analyst And Investor Conference On June 18, 2019

IQVIA To Host Financial Analyst And Investor Conference On June 18, 2019

IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV), will host an Analyst and Investor Conference in New York City on Tuesday, June 18, 2019.

A Big Biotech, an Online Apparel Retailer and Other Stocks That Look Good Short

BMRN, SFIX, INGR, VC and IQV all recently were downgraded by TheStreet's Quant Ratings.

TheStreet Quant Rating: C+ (Hold)